跳至主要内容
临床试验/NCT01224873
NCT01224873Unknown不适用

Diagnosis of Sceletal Metastases in c. Mammae: 18F-NaF-PET/Lowdose-CT Versus 99mTc HDP Bone Scintigraphy

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
110
试验地点
1

研究概览

简要总结

Breast cancer can metastasize to the bones, which leads to another treatment if bone metastases are detected. The purpose of the study is to determine, if fluoride PET/CT is superior to bone scintigraphy with technetium. On the other side, the investigators would like to see if FDG-PET/CT is a reliable alternative to dedicated bone imaging to detect bone metastases in patients with breast cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • histologically proven c. mammae
  • clinically suspicion of bone metastases

排除标准

  • age under 18 years
  • diabetes mellitus
  • pregnancy
  • other known malignant disease

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验